Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Dige

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
United European Gastroenterology Journal|December 15, 2025
Autologous Adipose Tissue Injection as Treatment for Ileoanal Pouch-Related FistulaeHayder Alqaisi, Anders Dige, Ole Thorlacius-Ussing, et al.
Techniques in Coloproctology|November 23, 2025
Treatment of chronic anal fissure in Crohn's disease patients with freshly collected autologous adipose tissue: a pilot studyAsmaa Sulaiman, Anders Dige, Andreas Hurup Nordholm, et al.
Danish Medical Journal|September 10, 2025
Diagnostic accuracy of IgA anti-tissue transglutaminase for the diagnosis of coeliac diseaseMaria Nyholm Iversen, Katrine Stribolt, Christian Lodberg Hvas, et al.
Basic & Clinical Pharmacology & Toxicology|June 4, 2013
Soluble adhesion molecules correlate with surface expression in an in vitro model of endothelial activationAnders G Kjaergaard, Anders Dige, Jan Krog, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 20, 2016
The use of the soluble adhesion molecules sE-selectin, sICAM-1, sVCAM-1, sPECAM-1 and their ligands CD11a and CD49d as diagnostic and prognostic biomarkers in septic and critically ill non-septic ICU patientsAnders G Kjaergaard, Anders Dige, Jeppe S Nielsen, et al.
Immunopharmacology and Immunotoxicology|May 11, 2018
Current, experimental, and future treatments in inflammatory bowel disease: a clinical reviewChristian L Hvas, Mia Bendix, Anders Dige, et al.
Scandinavian Journal of Gastroenterology|July 9, 2026
Diverging incidences of low-grade dysplasia and advanced neoplasia in inflammatory bowel disease: a nationwide Danish cohort studyJesper Winkler Andersen, Frederikke Schønfeldt Troelsen, Klaus Krogh, et al.
Dermatology (Basel, Switzerland)|March 15, 2023
Arthritis Hit Rate in Patients with Psoriasis Referred for Rheumatology EvaluationCatalina Hartmann Skovsgård, Trine Bay Laurberg, Anders Dige, et al.
Journal of Immunological Methods|December 5, 2009
Ethylene-Diamine-Tetra-Acetate (EDTA) mimics the effect of regulatory T cells in suppression assays: a potential pitfall when using AutoMACS-separated cellsAnders Dige, Christian Lodberg Hvas, Jens Kelsen, et al.
Journal of Crohn'S & Colitis|November 29, 2025
Cumulative incidence and risk factors for advanced neoplasia following inflammatory bowel disease-related low-grade dysplasia: a Danish nationwide cohort studyJesper W Andersen, Frederikke S Troelsen, David Haldrup, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
United European Gastroenterology Journal|December 15, 2025
Autologous Adipose Tissue Injection as Treatment for Ileoanal Pouch-Related FistulaeHayder Alqaisi, Anders Dige, Ole Thorlacius-Ussing, et al.
Techniques in Coloproctology|November 23, 2025
Treatment of chronic anal fissure in Crohn's disease patients with freshly collected autologous adipose tissue: a pilot studyAsmaa Sulaiman, Anders Dige, Andreas Hurup Nordholm, et al.
Danish Medical Journal|September 10, 2025
Diagnostic accuracy of IgA anti-tissue transglutaminase for the diagnosis of coeliac diseaseMaria Nyholm Iversen, Katrine Stribolt, Christian Lodberg Hvas, et al.
Basic & Clinical Pharmacology & Toxicology|June 4, 2013
Soluble adhesion molecules correlate with surface expression in an in vitro model of endothelial activationAnders G Kjaergaard, Anders Dige, Jan Krog, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 20, 2016
The use of the soluble adhesion molecules sE-selectin, sICAM-1, sVCAM-1, sPECAM-1 and their ligands CD11a and CD49d as diagnostic and prognostic biomarkers in septic and critically ill non-septic ICU patientsAnders G Kjaergaard, Anders Dige, Jeppe S Nielsen, et al.
Immunopharmacology and Immunotoxicology|May 11, 2018
Current, experimental, and future treatments in inflammatory bowel disease: a clinical reviewChristian L Hvas, Mia Bendix, Anders Dige, et al.
Scandinavian Journal of Gastroenterology|July 9, 2026
Diverging incidences of low-grade dysplasia and advanced neoplasia in inflammatory bowel disease: a nationwide Danish cohort studyJesper Winkler Andersen, Frederikke Schønfeldt Troelsen, Klaus Krogh, et al.
Dermatology (Basel, Switzerland)|March 15, 2023
Arthritis Hit Rate in Patients with Psoriasis Referred for Rheumatology EvaluationCatalina Hartmann Skovsgård, Trine Bay Laurberg, Anders Dige, et al.
Journal of Immunological Methods|December 5, 2009
Ethylene-Diamine-Tetra-Acetate (EDTA) mimics the effect of regulatory T cells in suppression assays: a potential pitfall when using AutoMACS-separated cellsAnders Dige, Christian Lodberg Hvas, Jens Kelsen, et al.
Journal of Crohn'S & Colitis|November 29, 2025
Cumulative incidence and risk factors for advanced neoplasia following inflammatory bowel disease-related low-grade dysplasia: a Danish nationwide cohort studyJesper W Andersen, Frederikke S Troelsen, David Haldrup, et al.
Pageof 6